Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells
- PMID: 35956952
- PMCID: PMC9370307
- DOI: 10.3390/molecules27155002
Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells
Abstract
The mechanism of ginsenoside Rh3 activity against cancer remains unclear. This study aimed to investigate the underlying mechanism. The effects of Rh3 on the cell proliferation, migration and invasion, and cycle and apoptosis were analyzed using CCK-8 assay, transwell migration assay and flow cytometry, respectively. The RNA transcriptome was sequenced and data were analyzed by R software. Protein expression and protein-protein interactions were determined by Western blotting and co-immunoprecipitation, respectively. The results showed Rh3 inhibited HCT116 cell proliferation, invasion, and migration, arrested cells at G1 phase; and increased apoptosis. Rh3 downregulated 314 genes and upregulated 371 genes. Gene Set Enrichment Analysis (GSEA) using The Kyoto Encyclopedia of Genes Genomics ranked DNA replication first, while GSEA using Gene Ontology ranked the initiation of DNA replication first. Compared with tumor data from The Cancer Genome Atlas (TCGA), most of genes related to DNA replication were oppositely regulated by Rh3. Furthermore, Rh3 down-regulated key protein expression related to DNA replication (Orc6, Cdt1, and Mcm2), but did not affect the loading of Mcm complexes onto ORC complexes nor the phosphorylation at ser139 of Mcm2. Therefore, Rh3 may inhibit colorectal cancer HCT116 cells by downregulation of genes related to DNA replication.
Keywords: DNA replication; colorectal cancer; ginsenoside (Rh3); proliferation; transcriptome analysis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Ginsenoside Rh3 Inhibits Proliferation and Induces Apoptosis of Colorectal Cancer Cells.Pharmacology. 2020;105(5-6):329-338. doi: 10.1159/000503821. Epub 2019 Oct 31. Pharmacology. 2020. PMID: 31671429
-
Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study.Pharmaceuticals (Basel). 2022 Jun 17;15(6):758. doi: 10.3390/ph15060758. Pharmaceuticals (Basel). 2022. PMID: 35745677 Free PMC article.
-
Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.Exp Mol Pathol. 2019 Feb;106:131-138. doi: 10.1016/j.yexmp.2019.01.003. Epub 2019 Jan 8. Exp Mol Pathol. 2019. Retraction in: Exp Mol Pathol. 2022 Aug;127:104785. doi: 10.1016/j.yexmp.2022.104785. PMID: 30633886 Retracted.
-
Integrated network pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells.Int J Biol Macromol. 2024 Dec;282(Pt 2):136832. doi: 10.1016/j.ijbiomac.2024.136832. Epub 2024 Oct 24. Int J Biol Macromol. 2024. PMID: 39461627
-
The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.Hum Cell. 2018 Jul;31(3):189-198. doi: 10.1007/s13577-017-0189-3. Epub 2018 Mar 26. Hum Cell. 2018. PMID: 29582366
Cited by
-
Therapeutic Applications of Ginseng Natural Compounds for Health Management.Int J Mol Sci. 2023 Dec 9;24(24):17290. doi: 10.3390/ijms242417290. Int J Mol Sci. 2023. PMID: 38139116 Free PMC article. Review.
-
Ginseng-Based Nanotherapeutics in Cancer Treatment: State-of-the-Art Progress, Tackling Gaps, and Translational Achievements.Curr Issues Mol Biol. 2025 Apr 3;47(4):250. doi: 10.3390/cimb47040250. Curr Issues Mol Biol. 2025. PMID: 40699649 Free PMC article. Review.
-
Ginsenoside Rh3-induced neurotoxicity involving the IP3R-Ca2+/NOX2/NF-κB signaling pathways.J Nat Med. 2025 Jul;79(4):791-806. doi: 10.1007/s11418-025-01912-8. Epub 2025 May 13. J Nat Med. 2025. PMID: 40360886
-
Bioinformatics study of the potential therapeutic effects of ginsenoside Rh3 in reversing insulin resistance.Front Mol Biosci. 2024 May 23;11:1339973. doi: 10.3389/fmolb.2024.1339973. eCollection 2024. Front Mol Biosci. 2024. PMID: 38845779 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous